PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
The Korean Journal of Internal Medicine10.3904/kjim.2015.1872017321125-136BCR-ABL1 transcripts (MR4.5) at post-transplant 3 months as an early predictor for long-term outcomes in chronic myeloid leukemiaSung-Eun Lee, Soo Young Choi, Soo-Hyun Kim, Hye-Young Song, Hea-Lyun Yoo, Mi-Young Lee, Ki-Hoon Kang, Hee-Jeong Hwang, Eun-Jung Jang, Dong-Wook Kimhttp://kjim.org/journal/view.php?doi=10.3904/kjim.2015.187, http://kjim.org/upload/kjim-2015-187.pdf, http://www.kjim.org/upload/kjim-2015-187.pdf
Acta Haematologica10.1159/00036817620141332237-241BCR-ABL1+ Acute Myeloid Leukemia: Clonal Selection of a BCR-ABL1- Subclone as a Cause of Refractory Disease with Nilotinib TreatmentNina Rosa Neuendorff, Michaela Schwarz, Philipp Hemmati, Seval Türkmen, Christiane Bommer, Thomas Burmeister, Bernd Dörken, Philipp le Coutre, Renate Arnold, Jörg Westermannhttps://www.karger.com/Article/Pdf/368176, https://www.karger.com/Article/Pdf/368176
Gene10.1016/j.gene.2017.06.0182017627202-206Impact of the BCR - ABL1 fusion transcripts on different responses to Imatinib and disease recurrence in Iranian patients with Chronic Myeloid LeukemiaGolale Rostami, Mohammad Hamid, Hasan Jalaeikhoohttps://api.elsevier.com/content/article/PII:S0378111917304687?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0378111917304687?httpAccept=text/plain
Leukemia Research10.1016/j.leukres.2012.12.0032013373349-356Decreased microRNA-30a levels are associated with enhanced ABL1 and BCR-ABL1 expression in chronic myeloid leukemiaYue Liu, Yanbin Song, Wenli Ma, Wenling Zheng, Hong Yinhttps://api.elsevier.com/content/article/PII:S0145212612004742?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0145212612004742?httpAccept=text/plain
Chronic Myeloid Leukemia10.1007/978-3-319-33198-0_5201671-87Management of Adverse Events Associated with ATP-Competitive BCR-ABL1 Tyrosine Kinase Inhibitors in Chronic Myeloid LeukemiaDelphine Reahttp://link.springer.com/content/pdf/10.1007/978-3-319-33198-0_5
Hematopathology10.1007/978-3-319-95309-0_50132019109-115Chronic Myeloid Leukemia, BCR-ABL1 PositiveHans H. Kreipehttp://link.springer.com/content/pdf/10.1007/978-3-319-95309-0_5013
Encyclopedia of Pathology10.1007/978-3-319-28845-1_5013-120191-8Chronic Myeloid Leukemia, BCR-ABL1 PositiveHans Kreipehttp://link.springer.com/content/pdf/10.1007/978-3-319-28845-1_5013-1
Clinical Lymphoma Myeloma and Leukemia10.1016/j.clml.2015.02.035201515S120-S128Mutations in the BCR-ABL1 Kinase Domain and Elsewhere in Chronic Myeloid LeukemiaSimona Soverini, Caterina de Benedittis, Manuela Mancini, Giovanni Martinellihttps://api.elsevier.com/content/article/PII:S2152265015000798?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S2152265015000798?httpAccept=text/plain
Leukemia10.1038/s41375-019-0562-1201933102358-2364Chronic myeloid leukemia: the concepts of resistance and persistence and the relationship with the BCR-ABL1 transcript typeMichele Baccarani, Gianantonio Rosti, Simona Soverinihttp://www.nature.com/articles/s41375-019-0562-1.pdf, http://www.nature.com/articles/s41375-019-0562-1, http://www.nature.com/articles/s41375-019-0562-1.pdf
Leukemia Research10.1016/j.leukres.2018.01.00520186574-79Therapeutic effects of tyrosine kinase inhibitors and subtypes of BCR-ABL1 transcripts in Japanese chronic myeloid leukemia patients with three-way chromosomal translocationsKoiti Inokuchi, Kazutaka Nakayama, Tetsuzo Tauchi, Tomoiku Takaku, Norio Yokose, Hiroki Yamaguchi, Takashi Kumagai, Norio Komatsu, Kazuma Ohyashikihttps://api.elsevier.com/content/article/PII:S0145212618300055?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0145212618300055?httpAccept=text/plain